Time to rehospitalization in patients with bipolar mania discharged on long-acting injectable or oral antipsychotics
- PMID: 33096327
- DOI: 10.1016/j.jad.2020.10.023
Time to rehospitalization in patients with bipolar mania discharged on long-acting injectable or oral antipsychotics
Abstract
Objective: This study aimed to analyze time to rehospitalization in patients with bipolar mania discharged on long-acting injectable antipsychotics (LAIs) or oral antipsychotics (OAPs). Additionally, temporal trends in LAI prescription were investigated.
Methods: Patients with bipolar mania discharged from the study hospital on antipsychotics between 2006 and 2018 were included. Survival analysis was used to compare time to rehospitalization within one year of discharge between patients discharged on LAIs and OAPs, and between FGA-LAIs (first- generation antipsychotic) and SGA-LAIs (second-generation antipsychotic). The Cochrane-Armitage trend test was used to test whether a temporal trend existed for LAI prescription rates during the study period.
Results: The LAI group (n = 224) had a significantly lower rehospitalization rate and a significantly longer time to rehospitalization than the OAP group (n = 3836). Rehospitalization rate and time to rehospitalization were not significantly different between patients discharged on FGA-LAIs or SGA-LAIs. The LAI prescription rate grew significantly from 2.20% in 2006 to 11.58% in 2018 (Z = 5.5843, p < 0.0001). The prescription rate of SGA-LAIs also increased significantly (Z = 7.7141, p < 0.0001), but not the prescription rate of FGA-LAIs.
Limitations: The treatment allocation is not randomized in this retrospective study. Furthermore, various clinical characteristics were unavailable in our analysis, such as symptom severity, functional impairment, and others.
Conclusions: LAIs were significantly superior to OAPs in reducing rehospitalization risk. However, SGA-LAIs were comparable with FGA-LAIs in reducing rehospitalization risk. Use of LAIs increased significantly in discharged patients with bipolar disorder during the study period, especially SGA-LAIs.
Keywords: Adherence; Bipolar mania; Long-acting injectable antipsychotics; Mood stabilizers; Rehospitalization.
Copyright © 2020. Published by Elsevier B.V.
Similar articles
-
Time to Rehospitalization in Patients With Schizophrenia Receiving Long-Acting Injectable Antipsychotics or Oral Antipsychotics.Int J Neuropsychopharmacol. 2019 Sep 1;22(9):541-547. doi: 10.1093/ijnp/pyz035. Int J Neuropsychopharmacol. 2019. PMID: 31260538 Free PMC article.
-
Time to rehospitalization in involuntarily hospitalized individuals suffering from schizophrenia discharged on long-acting injectable antipsychotics or oral antipsychotics.Ther Adv Psychopharmacol. 2022 Mar 23;12:20451253221079165. doi: 10.1177/20451253221079165. eCollection 2022. Ther Adv Psychopharmacol. 2022. PMID: 35340566 Free PMC article.
-
A Comparison of Long-Acting Injectable Antipsychotics With Oral Antipsychotics on Time to Rehospitalization Within 1 Year of Discharge in Elderly Patients With Schizophrenia.Am J Geriatr Psychiatry. 2020 Jan;28(1):23-30. doi: 10.1016/j.jagp.2019.08.005. Epub 2019 Aug 9. Am J Geriatr Psychiatry. 2020. PMID: 31481273
-
Second-generation antipsychotic long-acting injections in bipolar disorder: Systematic review and meta-analysis.Bipolar Disord. 2018 Dec;20(8):687-696. doi: 10.1111/bdi.12707. Epub 2018 Nov 11. Bipolar Disord. 2018. PMID: 30417552 Free PMC article.
-
Long-acting injectable vs oral antipsychotics for relapse prevention in schizophrenia: a meta-analysis of randomized trials.Schizophr Bull. 2014 Jan;40(1):192-213. doi: 10.1093/schbul/sbs150. Epub 2012 Dec 17. Schizophr Bull. 2014. PMID: 23256986 Free PMC article.
Cited by
-
Twenty-year medication use trends in first-episode bipolar disorder.Acta Psychiatr Scand. 2022 Dec;146(6):583-593. doi: 10.1111/acps.13504. Epub 2022 Oct 12. Acta Psychiatr Scand. 2022. PMID: 36177718 Free PMC article.
-
Long-acting injectable antipsychotics for the treatment of bipolar disorder: evidence from mirror-image studies.Ther Adv Psychopharmacol. 2023 Mar 25;13:20451253231163682. doi: 10.1177/20451253231163682. eCollection 2023. Ther Adv Psychopharmacol. 2023. PMID: 36994116 Free PMC article. Review.
-
Early use of long-acting injectable antipsychotics in bipolar disorder type I: An expert consensus.Bipolar Disord. 2025 Feb;27(1):7-16. doi: 10.1111/bdi.13498. Epub 2024 Oct 22. Bipolar Disord. 2025. PMID: 39438154 Free PMC article. Review.
-
Avoiding revolving door and homelessness: The need to improve care transition interventions in psychiatry and mental health.Front Psychiatry. 2022 Sep 26;13:1021926. doi: 10.3389/fpsyt.2022.1021926. eCollection 2022. Front Psychiatry. 2022. PMID: 36226101 Free PMC article. No abstract available.
-
High Rate of Discontinuation during Long-Acting Injectable Antipsychotic Treatment in Patients with Psychotic Disorders.Biomedicines. 2023 Jan 22;11(2):314. doi: 10.3390/biomedicines11020314. Biomedicines. 2023. PMID: 36830850 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous